X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE J.B.CHEMICALS TTK HEALTHCARE/
J.B.CHEMICALS
 
P/E (TTM) x 27.6 14.2 195.0% View Chart
P/BV x 6.1 2.2 272.4% View Chart
Dividend Yield % 0.5 0.2 275.2%  

Financials

 TTK HEALTHCARE   J.B.CHEMICALS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
J.B.CHEMICALS
Mar-16
TTK HEALTHCARE/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs663318 208.6%   
Low Rs399200 200.0%   
Sales per share (Unadj.) Rs535.6148.0 362.0%  
Earnings per share (Unadj.) Rs15.919.1 83.6%  
Cash flow per share (Unadj.) Rs20.023.9 83.6%  
Dividends per share (Unadj.) Rs4.000.50 800.0%  
Dividend yield (eoy) %0.80.2 389.8%  
Book value per share (Unadj.) Rs137.6128.9 106.7%  
Shares outstanding (eoy) m7.7784.82 9.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.7 56.7%   
Avg P/E ratio x33.313.6 245.6%  
P/CF ratio (eoy) x26.510.8 245.4%  
Price / Book Value ratio x3.92.0 192.3%  
Dividend payout %25.12.6 957.4%   
Avg Mkt Cap Rs m4,12721,951 18.8%   
No. of employees `0001.72.7 62.5%   
Total wages/salary Rs m6071,841 32.9%   
Avg. sales/employee Rs Th2,436.74,590.9 53.1%   
Avg. wages/employee Rs Th355.2673.4 52.7%   
Avg. net profit/employee Rs Th72.5592.1 12.3%   
INCOME DATA
Net Sales Rs m4,16212,551 33.2%  
Other income Rs m61542 11.3%   
Total revenues Rs m4,22313,093 32.3%   
Gross profit Rs m1972,055 9.6%  
Depreciation Rs m32412 7.7%   
Interest Rs m3096 31.2%   
Profit before tax Rs m1972,088 9.4%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73469 15.5%   
Profit after tax Rs m1241,619 7.7%  
Gross profit margin %4.716.4 28.9%  
Effective tax rate %37.022.5 164.8%   
Net profit margin %3.012.9 23.1%  
BALANCE SHEET DATA
Current assets Rs m1,6297,778 20.9%   
Current liabilities Rs m1,0584,358 24.3%   
Net working cap to sales %13.727.2 50.3%  
Current ratio x1.51.8 86.3%  
Inventory Days Days3055 54.5%  
Debtors Days Days3480 42.0%  
Net fixed assets Rs m5565,713 9.7%   
Share capital Rs m78170 45.8%   
"Free" reserves Rs m87810,547 8.3%   
Net worth Rs m1,06910,937 9.8%   
Long term debt Rs m1590-   
Total assets Rs m2,39915,574 15.4%  
Interest coverage x7.622.8 33.2%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.8 215.2%   
Return on assets %6.411.0 58.2%  
Return on equity %11.614.8 78.3%  
Return on capital %18.520.0 92.4%  
Exports to sales %0.848.7 1.6%   
Imports to sales %1.47.1 19.8%   
Exports (fob) Rs m336,115 0.5%   
Imports (cif) Rs m58889 6.6%   
Fx inflow Rs m336,169 0.5%   
Fx outflow Rs m631,285 4.9%   
Net fx Rs m-304,884 -0.6%   
CASH FLOW
From Operations Rs m1271,397 9.1%  
From Investments Rs m-146-320 45.6%  
From Financial Activity Rs m22-1,196 -1.8%  
Net Cashflow Rs m3-102 -2.4%  

Share Holding

Indian Promoters % 65.4 55.4 118.1%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 3.7 3.4 109.1%  
FIIs % 5.2 3.9 133.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 37.0 69.7%  
Shareholders   12,723 30,437 41.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ELDER PHARMA  FDC LTD.  ORCHID PHARMA LTD  DISHMAN PHARMA  FULFORD INDIA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Vedanta & Kotak Mahindra Top Losers(Closing)

Indian share markets ended marginally lower on Monday amid weak global cues. The BSE Metal index, however, lost 1.7 amid rising global trade war fears.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jun 18, 2018 03:35 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - AUROBINDO PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS